;
Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Elusys management update

    Elusys Therapeutics Inc., Pine Brook, N.J. Business: Antibodies, Infectious, Autoimmune Hired: Lawrence Gyenes as CFO, formerly CFO of Columbia Laboratories Inc.

    Published on 4/14/2014
  • Gen9 management update

    Gen9 Inc., Cambridge, Mass. Business: Genomics, Supply/Service Hired: Jennifer Camacho as chief legal officer and business counsel, a newly created role, formerly a partner at Greenberg Traurig LLP

    Published on 4/14/2014
  • Genocea management update

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Business: Infectious Hired: Jonathan Poole as CFO, formerly SVP of finance for pipeline and technical operations at Shire plc

    Published on 4/14/2014
  • GTx management update

    GTx Inc. (NASDAQ:GTXI), Memphis, Tenn. Business: Cancer, Musculoskeletal Transitioned: President and COO Marc Hanover to interim CEO and a director; he replaces Mitchell Steiner, who will also step down as vice chairman

    Published on 4/14/2014
  • HTG Molecular Diagnostics management update

    HTG Molecular Diagnostics Inc., Tucson, Ariz. Business: Genomics, Supply/Service, Diagnostic Hired: Patrick Roche as SVP for in vitro diagnostic assay development, formerly VP of translational diagnostics at Roche's …

    Published on 4/14/2014
  • Icon Bioscience management update

    Icon Bioscience Inc., Sunnyvale, Calif. Business: Ophthalmic Hired: David Tierney as president and CEO, formerly president and COO of Oceana Therapeutics Inc., which Salix Pharmaceuticals Inc. acquired

    Published on 4/14/2014
  • MediciNova management update

    MediciNova Inc. (NASDAQ:MNOV; JASDAQ:4875), San Diego, Calif. Business: Genitourinary, Inflammation, Neurology Hired: Esther van den Boom as CFO, formerly a senior manager at Ernst & Young LLP; she replaces President …

    Published on 4/14/2014
  • MEI Pharma management update

    MEI Pharma Inc. (NASDAQ:MEIP), San Diego, Calif. Business: Cancer Hired: David Urso as SVP of corporate development and general counsel, formerly COO and general counsel at Tioga Pharmaceuticals Inc.

    Published on 4/14/2014
  • Mela Sciences management update

    Mela Sciences Inc. (NASDAQ:MELA), Irvington, N.Y. Business: Diagnostic Hired: Robert Cook as CFO, formerly SVP and CFO of Immune Pharmaceuticals Inc.

    Published on 4/14/2014
  • Novartis management update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals Hired: Richard Francis as division head of Novartis' Sandoz International GmbH generics unit, effective May 1, formerly SVP of U.S. …

    Published on 4/14/2014
  • Novavax management update

    Novavax Inc. (NASDAQ:NVAX), Rockville, Md. Business: Infectious Hired: Cynthia Oliver as SVP of process development operations, formerly VP of process biochemistry and formulation sciences at the MedImmune LLC biologics…

    Published on 4/14/2014
  • NuCana BioMed board of directors update

    NuCana Biomed Ltd., Edinburgh, U.K. Business: Cancer Appointed: Gerald Chan, co-founder and chairman at Morningside Ventures; and James Healy, general partner at Sofinnova Ventures

    Published on 4/14/2014
  • Piqur board of directors update

    Piqur Therapeutics AG, Basel, Switzerland Business: Cancer Appointed: Guido Magni, venture partner at Versant Ventures

    Published on 4/14/2014
  • RefleXion Medical board of directors update

    RefleXion Medical Inc., Burlingame, Calif. Business: Cancer Appointed: Bill Burkoth, executive director at Pfizer Venture Investments; Colin Cahill, a VP at Venrock; and Antoine Papiernik, managing partner at Sofinnova …

    Published on 4/14/2014
  • Sorrento management update

    Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Business: Cancer, Antibodies Hired: Ian Walters as SVP of translational medicine and corporate development

    Published on 4/14/2014
  • Spinifex board of directors update

    Spinifex Pharmaceuticals Pty. Ltd., South Yarra, Australia Business: Neurology Appointed: Brent Ahrens, general partner at Canaan Partners; Steve Collins, formerly president and CEO of NeuroTherapeutics Pharma Inc.; and…

    Published on 4/14/2014
  • Tal Medical management update

    Tal Medical Inc., Boston, Mass. Business: Neurology Hired: Jan Skvarka as president, CEO and a director, formerly a partner at Bain & Company Inc.; he replaces Chairman Steve Paul, who was acting CEO and now transitions…

    Published on 4/14/2014
  • uniQure management update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Business: Hematology, Neurology, Endocrine/Metabolic Departing: Piers Morgan as CFO, effective May 20 Hired: Eric Goossens as COO, formerly a site director at …

    Published on 4/14/2014
  • 23andMe management update

    23andMe Inc., Mountain View, Calif. Business: Diagnostic Hired: Kathy Hibbs as chief legal and regulatory officer, formerly SVP and general counsel at Genomic Health Inc.

    Published on 4/7/2014
  • Aastrom management update

    Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Hired: David Recker as CMO, formerly SVP of clinical sciences at the Takeda Global Research & Development Center Inc. unit of Takeda …

    Published on 4/7/2014
  • Amarantus Bioscience management update

    Amarantus Bioscience Holdings Inc. (OTCQB:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Hired: Robert Farrell as CFO, formerly CFO of Sanovas Inc.; he succeeds Marc Faerber, who becomes corporate …

    Published on 4/7/2014
  • Ariad management update

    Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass. Business: Cancer Hired: Hugh Cole as SVP and CBO, formerly SVP of strategic planning and program management at Shire plc

    Published on 4/7/2014
  • Atossa Genetics management update

    Atossa Genetics Inc. (NASDAQ:ATOS), Seattle, Wash. Business: Diagnostic Hired: Ben Chen as SVP of global regulatory affairs and quality assurance, a newly created position, formerly VP of global quality assurance and …

    Published on 4/7/2014
  • Bio-Path management update

    Bio-Path Holdings Inc. (NASDAQ:BPTH), Houston, Texas Business: Cancer Hired: Ulrich Mueller as COO, formerly a VP at the Fred Hutchinson Cancer Research Center

    Published on 4/7/2014
  • Catalyst Pharma management update

    Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), Coral Gables, Fla. Business: Neurology Hired: Barrett McGrath as chief commercial officer, a newly created position, formerly VP of commercial development at …

    Published on 4/7/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993